Goat Polyclonal ATP5A antibody. Suitable for WB and reacts with Mouse, Rat, Pig, Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human ATP5F1A aa 50-100.
pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: 99% Tris buffer, 0.5% BSA
WB | |
---|---|
Human | Tested |
Mouse | Tested |
Rat | Tested |
Chimpanzee | Predicted |
Cow | Predicted |
Dog | Predicted |
Orangutan | Predicted |
Pig | Tested |
Xenopus laevis | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 0.01000-0.03000 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Species Rat | Dilution info 0.01000-0.03000 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Species Pig | Dilution info 0.01000-0.03000 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Species Human | Dilution info 0.01000-0.03000 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Species | Dilution info | Notes |
---|---|---|
Species Cow, Dog, Xenopus laevis, Chimpanzee, Orangutan | Dilution info - | Notes - |
Select an associated product type
Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Subunits alpha and beta form the catalytic core in F(1). Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits. Subunit alpha does not bear the catalytic high-affinity ATP-binding sites (By similarity). Binds the bacterial siderophore enterobactin and can promote mitochondrial accumulation of enterobactin-derived iron ions (PubMed:30146159).
ATP5A, ATP5A1, ATP5AL2, ATPM, ATP5F1A, ATP synthase F1 subunit alpha
Goat Polyclonal ATP5A antibody. Suitable for WB and reacts with Mouse, Rat, Pig, Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human ATP5F1A aa 50-100.
pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: 99% Tris buffer, 0.5% BSA
ab188107 is expected to recognize all reported isoforms (NP_004037.1; NP_001244263.1; NP_001001935.1).
ab188107 was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
ATP5A also known as ATP synthase F1 subunit alpha is a protein important for cellular energy production. As part of the ATP synthase complex it plays a mechanical role in synthesizing ATP from ADP and inorganic phosphate. The ATP5A protein has a molecular weight of approximately 55 kDa and is widely expressed in the inner mitochondrial membrane across different cell types. Its central function lies in its ability to harness the energy of the proton gradient generated by the electron transport chain to catalyze ATP synthesis.
ATP5A is essential in cellular respiration serving as a catalytic core of the F1 component of ATP synthase. As part of the multi-subunit enzyme complex ATP synthase is responsible for ATP production the primary energy currency in cells. The ATP5A subunit works in conjunction with other subunits of the enzyme oligomer to facilitate the conversion of energy released during oxidative phosphorylation into a usable form. The protein's efficiency in this biological role underpins its importance in sustaining cellular energy homeostasis.
ATP5A plays a pivotal role in oxidative phosphorylation and the electron transport chain integral components of cellular respiration. The oxidative phosphorylation pathway depends on this protein to manage the synthesis of ATP molecules while the electron transport chain creates the proton gradient necessary for ATP production. ATP5A is functionally connected to other proteins in these pathways such as ATP5B and cytochrome c oxidase working in a coordinated manner to ensure efficient energy transfer and maintenance.
ATP5A is implicative in mitochondrial disorders and neurodegenerative diseases such as Leigh syndrome and Parkinson's disease. These conditions often arise from deficits in ATP production where ineffective ATP synthase activity can contribute to cellular energy failures. In the context of Parkinson’s disease for instance ATP5A interactions with other proteins like Parkin can contribute to mitochondrial dysfunction an important pathological feature of the disorder. Through such associations alterations in ATP5A activity can significantly impact disease progression and symptomatology.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ATP5A Western blot staining using goat Anti-ATP5A antibody
Primary incubation was 1 hour.
All lanes: Western blot - Anti-ATP5A antibody - Mitochondrial Marker (ab188107) at 0.01 µg/mL
Lane 1: Human heart lysate (in RIPA buffer) at 35 µg
Lane 2: Fetal mouse heart lysate (in RIPA buffer) at 35 µg
Lane 3: Adult mouse heart lysate (in RIPA buffer) at 35 µg
Lane 4: Adult rat heart lysate (in RIPA buffer) at 35 µg
Developed using the ECL technique.
Predicted band size: 60 kDa
Observed band size: 52 kDa
ATP5A Western blot staining of Pig heart lysate (in RIPA buffer) using goat Anti-ATP5A antibody
Primary incubation was 1 hour.
All lanes: Western blot - Anti-ATP5A antibody - Mitochondrial Marker (ab188107) at 0.01 µg/mL
All lanes: Pig heart lysate (in RIPA buffer) at 35 µg
Developed using the ECL technique.
Predicted band size: 60 kDa
Observed band size: 55 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com